Medtronic MiniMed recalled 95,704 MiniMed 770G insulin pumps worldwide after finding insulin delivery can misbehave when the pump height changes. Over-delivery can cause severe hypoglycemia and death; under-delivery can cause hyperglycemia and death. Stop using the device and follow the manufacturer’s recall instructions immediately.
Quick Facts at a Glance
Recall Date
February 13, 2026
Hazard Level
HIGH
Brand
Medtronic MiniMed
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL
Hazard Information
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medtronic MiniMed, Inc. or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
No spamUnsubscribe anytime
About This Product
This insulin pump delivers continuous subcutaneous insulin to people with diabetes. The MiniMed 770G and related pumps are used to automate insulin delivery.
Why This Is Dangerous
The device’s height relative to the infusion site can alter insulin flow due to hydrostatic and hydrodynamic pressure changes. Over-delivery risks hypoglycemia and death; under-delivery risks hyperglycemia, dehydration, DKA, and death.
Industry Context
This recall is not stated as part of a broader industry pattern.
Real-World Impact
Consumers could face life-threatening diabetes complications if the device mis-delivers insulin. The recall involves a large, global population of users.
Practical Guidance
How to identify if yours is affected
Identify your pump model and serial or UDI labels.
Compare your model against the affected list (MMT-1880, 1881, 1882, 1890, 1891, 1892).
Check packaging and device labels for model numbers and UDI codes.
Where to find product info
Look on the device label, user guide, and original packaging for model numbers and UDI. Manufacturer recall notices will detail next steps.
What timeline to expect
Refund or replacement processing will follow manufacturer instructions; typical recall timelines range from several weeks to a few months.
If the manufacturer is unresponsive
Document all communications with the manufacturer.
Contact your healthcare provider for interim insulin management guidance.
If the manufacturer is nonresponsive, file a consumer complaint with federal safety agencies.
How to prevent similar issues
Avoid purchasing older Paradigm, 600 series, or BLE 700 series pumps for replacement until updated guidance is issued.
Verify recall status before replacing devices.
Ask clinicians about non-pump insulin management during a recall window.
Documentation advice
Keep the recall notice, your pump’s model and serial numbers, purchase receipts, and all communications with the manufacturer and healthcare providers.
Product Details
Product: MiniMed 770G Insulin Pump
Brand: Medtronic MiniMed
Models: MMT-1880, MMT-1881, MMT-1882, MMT-1890, MMT-1891, MMT-1892
Distribution: Worldwide, including US states and international markets
Original recall date: 2026-02-13
Recall number: Z-1742-2026
Quantity: 95,704 units
Associated series: Paradigm, 600 series, BLE 700 series
URL: https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-1742-2026
Price: Unknown
Sold since: Unknown
Reported Incidents
No injuries or incidents have been reported.
Key Facts
95,704 units recalled worldwide
Affects Paradigm, 600 series, and BLE 700 series pumps
Recall date 2026-02-13; active status
Over-delivery can cause severe hypoglycemia and death; under-delivery can cause severe hyperglycemia
Stop using immediately and follow manufacturer instructions
Medtronic recalled 453,144 MiniMed 780G insulin pumps worldwide after reports of unintended insulin delivery when the pump height changes relative to the infusion site. The defect stems from gravity-driven pressure changes affecting hydrostatic delivery. Patients and caregivers should stop using the devices immediately and follow the recall notice, contacting Medtronic MiniMed or their clinician’s
Medtronic recalled 13,429 MiniMed insulin pumps worldwide after identifying unintended insulin delivery errors. The issue occurs when the pump height relative to the infusion site changes, causing over-delivery or under-delivery of insulin. Patients should stop using the device and contact Medtronic for instructions.
Medtronic MiniMed recalled 24,946 MiniMed 740G insulin pumps worldwide after identifying unintended insulin delivery when the pump height changes relative to the infusion site. The defect can cause over-delivery or under-delivery of insulin due to gravity-driven pressure changes. Patients should stop using the device and contact Medtronic MiniMed for instructions on recall steps, refunds or a swap
Medtronic MiniMed recalled 26,647 Paradigm REAL-Time Revel insulin pumps distributed worldwide, including in the United States. A design flaw can cause insulin to be over- or under-delivered when the pump height changes relative to the infusion site. Patients and health providers should stop using the device immediately and follow the manufacturer’s recall instructions. The recall covers Paradigm,
Medtronic MiniMed recalled 37,458 insulin pumps sold worldwide through healthcare providers, including the MiniMed 720G, after finding that a pump raised above or lowered relative to the infusion site can deliver insulin too much or too little. The defect stems from changes in gravitational force affecting hydrostatic and hydrodynamic pressures at the infusion site. Patients should stop using the
Medtronic MiniMed recalls 55,724 Paradigm REAL-Time Veo insulin pumps distributed worldwide. The pumps can deliver too much insulin when raised or too little when lowered relative to the infusion site due to gravity-driven pressure changes. Patients should stop using the device and contact Medtronic MiniMed or their healthcare provider for instructions and refunds.
Medtronic MiniMed recalled 13,811 MiniMed 700G insulin pumps sold worldwide through multiple retailers. The pumps can deliver too much or too little insulin when the pump height relative to the infusion site changes due to gravity. Consumers should stop using the device and follow recall instructions in the letter notice sent to affected users.
Medtronic MiniMed recalled 29,074 Paradigm Real-Time insulin pumps worldwide. The devices may deliver insulin improperly when the pump is elevated or lowered relative to the infusion site due to gravitational effects. Patients should stop using the pumps immediately and follow recall instructions from the manufacturer and their healthcare provider.